Implementing evidence-based strategies to improve HPV vaccine delivery

Melissa B. Gilkey, Michael J. Parks, Marjorie A. Margolis, Annie-Laurie McRee, Jason V. Terk

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

BACKGROUND: High-quality evidence indicates that intervening with health care providers improves human papillomavirus (HPV) vaccine delivery. However, scaling up evidence-based strategies in real-world clinical practice remains challenging. We sought to improve the reach and impact of strategies for HPV vaccination quality improvement (QI) through local adaptation and implementation in a large, not-for-profit health care system. METHODS: We conducted an HPV vaccination QI program using existing materials to support physician training coupled with assessment and feedback. Local physicians with high HPV vaccination rates facilitated training, which included didactic instruction and video vignettes modeling effective communication. We randomly assigned 25 clinics with 77 physicians to the QI arm or the wait-list control arm. We used hierarchical linear models to assess HPV vaccination coverage ($1 dose) over 6 months among patients aged 12 to 14. RESULTS: Of 45 physicians in the QI arm, the program reached 43 (95%) with training plus assessment and feedback. In the overall sample, HPV vaccination coverage increased in both the QI and control arms (8.6 vs 6.4 percentage points, respectively), although the 2.2–percentage point difference did not reach statistical significance. Sensitivity analyses that excluded physicians with poor data quality indicated a statistically significant advantage of 3.3 percentage points for QI versus control (b = 0.034; SE = 0.015; P, .05). CONCLUSIONS: Our locally adapted QI program achieved excellent reach, with small improvements in HPV vaccination coverage. Future implementation research is needed to bolster program impact and support health systems in leveraging local resources to conduct these programs efficiently.

Original languageEnglish (US)
Article numbere20182500
JournalPediatrics
Volume144
Issue number1
DOIs
StatePublished - Jan 1 2019

Fingerprint

Papillomavirus Vaccines
Quality Improvement
Vaccination
Physicians
Training Support
Quality Control
Health Personnel
Linear Models
Communication
Delivery of Health Care
Health
Research

Cite this

Implementing evidence-based strategies to improve HPV vaccine delivery. / Gilkey, Melissa B.; Parks, Michael J.; Margolis, Marjorie A.; McRee, Annie-Laurie; Terk, Jason V.

In: Pediatrics, Vol. 144, No. 1, e20182500, 01.01.2019.

Research output: Contribution to journalArticle

Gilkey, Melissa B. ; Parks, Michael J. ; Margolis, Marjorie A. ; McRee, Annie-Laurie ; Terk, Jason V. / Implementing evidence-based strategies to improve HPV vaccine delivery. In: Pediatrics. 2019 ; Vol. 144, No. 1.
@article{1261872133f94a9d8177224cc5cea7bf,
title = "Implementing evidence-based strategies to improve HPV vaccine delivery",
abstract = "BACKGROUND: High-quality evidence indicates that intervening with health care providers improves human papillomavirus (HPV) vaccine delivery. However, scaling up evidence-based strategies in real-world clinical practice remains challenging. We sought to improve the reach and impact of strategies for HPV vaccination quality improvement (QI) through local adaptation and implementation in a large, not-for-profit health care system. METHODS: We conducted an HPV vaccination QI program using existing materials to support physician training coupled with assessment and feedback. Local physicians with high HPV vaccination rates facilitated training, which included didactic instruction and video vignettes modeling effective communication. We randomly assigned 25 clinics with 77 physicians to the QI arm or the wait-list control arm. We used hierarchical linear models to assess HPV vaccination coverage ($1 dose) over 6 months among patients aged 12 to 14. RESULTS: Of 45 physicians in the QI arm, the program reached 43 (95{\%}) with training plus assessment and feedback. In the overall sample, HPV vaccination coverage increased in both the QI and control arms (8.6 vs 6.4 percentage points, respectively), although the 2.2–percentage point difference did not reach statistical significance. Sensitivity analyses that excluded physicians with poor data quality indicated a statistically significant advantage of 3.3 percentage points for QI versus control (b = 0.034; SE = 0.015; P, .05). CONCLUSIONS: Our locally adapted QI program achieved excellent reach, with small improvements in HPV vaccination coverage. Future implementation research is needed to bolster program impact and support health systems in leveraging local resources to conduct these programs efficiently.",
author = "Gilkey, {Melissa B.} and Parks, {Michael J.} and Margolis, {Marjorie A.} and Annie-Laurie McRee and Terk, {Jason V.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1542/peds.2018-2500",
language = "English (US)",
volume = "144",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "1",

}

TY - JOUR

T1 - Implementing evidence-based strategies to improve HPV vaccine delivery

AU - Gilkey, Melissa B.

AU - Parks, Michael J.

AU - Margolis, Marjorie A.

AU - McRee, Annie-Laurie

AU - Terk, Jason V.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - BACKGROUND: High-quality evidence indicates that intervening with health care providers improves human papillomavirus (HPV) vaccine delivery. However, scaling up evidence-based strategies in real-world clinical practice remains challenging. We sought to improve the reach and impact of strategies for HPV vaccination quality improvement (QI) through local adaptation and implementation in a large, not-for-profit health care system. METHODS: We conducted an HPV vaccination QI program using existing materials to support physician training coupled with assessment and feedback. Local physicians with high HPV vaccination rates facilitated training, which included didactic instruction and video vignettes modeling effective communication. We randomly assigned 25 clinics with 77 physicians to the QI arm or the wait-list control arm. We used hierarchical linear models to assess HPV vaccination coverage ($1 dose) over 6 months among patients aged 12 to 14. RESULTS: Of 45 physicians in the QI arm, the program reached 43 (95%) with training plus assessment and feedback. In the overall sample, HPV vaccination coverage increased in both the QI and control arms (8.6 vs 6.4 percentage points, respectively), although the 2.2–percentage point difference did not reach statistical significance. Sensitivity analyses that excluded physicians with poor data quality indicated a statistically significant advantage of 3.3 percentage points for QI versus control (b = 0.034; SE = 0.015; P, .05). CONCLUSIONS: Our locally adapted QI program achieved excellent reach, with small improvements in HPV vaccination coverage. Future implementation research is needed to bolster program impact and support health systems in leveraging local resources to conduct these programs efficiently.

AB - BACKGROUND: High-quality evidence indicates that intervening with health care providers improves human papillomavirus (HPV) vaccine delivery. However, scaling up evidence-based strategies in real-world clinical practice remains challenging. We sought to improve the reach and impact of strategies for HPV vaccination quality improvement (QI) through local adaptation and implementation in a large, not-for-profit health care system. METHODS: We conducted an HPV vaccination QI program using existing materials to support physician training coupled with assessment and feedback. Local physicians with high HPV vaccination rates facilitated training, which included didactic instruction and video vignettes modeling effective communication. We randomly assigned 25 clinics with 77 physicians to the QI arm or the wait-list control arm. We used hierarchical linear models to assess HPV vaccination coverage ($1 dose) over 6 months among patients aged 12 to 14. RESULTS: Of 45 physicians in the QI arm, the program reached 43 (95%) with training plus assessment and feedback. In the overall sample, HPV vaccination coverage increased in both the QI and control arms (8.6 vs 6.4 percentage points, respectively), although the 2.2–percentage point difference did not reach statistical significance. Sensitivity analyses that excluded physicians with poor data quality indicated a statistically significant advantage of 3.3 percentage points for QI versus control (b = 0.034; SE = 0.015; P, .05). CONCLUSIONS: Our locally adapted QI program achieved excellent reach, with small improvements in HPV vaccination coverage. Future implementation research is needed to bolster program impact and support health systems in leveraging local resources to conduct these programs efficiently.

UR - http://www.scopus.com/inward/record.url?scp=85068912109&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068912109&partnerID=8YFLogxK

U2 - 10.1542/peds.2018-2500

DO - 10.1542/peds.2018-2500

M3 - Article

VL - 144

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 1

M1 - e20182500

ER -